Month: January 2024

IK-930 Receives Orphan Drug Designation for EHE

By EHE Foundation / January 10, 2024 / Comments Off on IK-930 Receives Orphan Drug Designation for EHE

Ikena Oncology has shared that on December 14th, 2023, the Food and Drug Administration (FDA) granted Orphan Drug Designation to IK-930 for the treatment of epithelioid hemangioendothelioma (EHE). We are excited about this designation following initial positive data from the IK-930 Phase I clinical trial published in Ikena’s November 9th press release. What does this […]